Interstitial Lung Disease and Psoriasis in a Child With Aicardi-Goutières Syndrome

Efficacy and Adverse Events During Janus Kinase Inhibitor Treatment of SAVI Syndrome

(2019) Stefano Volpi et al.   JOURNAL OF CLINICAL IMMUNOLOGY

JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies

(2018) Gina A. Montealegre Sanchez et al.   JOURNAL OF CLINICAL INVESTIGATION

An open-label trial of JAK 1/2 blockade in progressive IFIH1 -associated neuroinflammation

(2018) Kavitha Kothur et al.   NEUROLOGY

Benefit-risk of tofacitinib in patients with moderate to severe chronic plaque psoriasis: Pooled analysis across 6 clinical trials

(2018) B.E. Strober et al.   BRITISH JOURNAL OF DERMATOLOGY

Aicardi goutières syndrome is associated with pulmonary hypertension

(2018) Laura A. Adang et al.   MOLECULAR GENETICS AND METABOLISM

Efficacy of JAK1/2 inhibition in the treatment of chilblain lupus due to TREX1 deficiency

(2018) Coralie Briand et al.   ANNALS OF THE RHEUMATIC DISEASES

JAK 1/2 Blockade in MDA5 Gain-of-Function

(2018) Kirsty E. McLellan et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Herpes Zoster in Tofacitinib: Risk is Further Increased with Glucocorticoids but not Methotrexate

(2018) Jeffrey R Curtis et al.   ARTHRITIS CARE & RESEARCH

Musculoskeletal Disease in MDA5-Related Type I Interferonopathy: A Mendelian Mimic of Jaccoud's Arthropathy

(2017) Luciana Martins de Carvalho et al.   Arthritis & Rheumatology

Familial chilblain lupus due to a gain-of-function mutation in STING

(2016) Nadja König et al.   ANNALS OF THE RHEUMATIC DISEASES

Type I interferonopathies in pediatric rheumatology

(2016) Stefano Volpi et al.   Pediatric Rheumatology

A Specific IFIH1 Gain-of-Function Mutation Causes Singleton-Merten Syndrome

(2015) Frank Rutsch et al.   AMERICAN JOURNAL OF HUMAN GENETICS

Unusual cutaneous features associated with a heterozygous gain-of-function mutation inIFIH1: overlap between Aicardi-Goutières and Singleton-Merten syndromes

(2015) A.-C. Bursztejn et al.   BRITISH JOURNAL OF DERMATOLOGY

Brief Report:IFIH1Mutation Causes Systemic Lupus Erythematosus With Selective IgA Deficiency

(2015) Lien Van Eyck et al.   Arthritis & Rheumatology

Aicardi-Goutières Syndrome Is Caused by IFIH1 Mutations

(2014) Hirotsugu Oda et al.   AMERICAN JOURNAL OF HUMAN GENETICS

Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling

(2014) Gillian I Rice et al.   NATURE GENETICS

Activated STING in a Vascular and Pulmonary Syndrome

(2014) Yin Liu et al.   NEW ENGLAND JOURNAL OF MEDICINE

Induction and exacerbation of psoriasis with Interferon-alpha therapy for hepatitis C: A review and analysis of 36 cases

(2012) M. Afshar et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Carriers of Rare Missense Variants in IFIH1 Are Protected from Psoriasis

(2010) Yonghong Li et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension

(2009) et al.   CIRCULATION

Cutaneous histopathological findings of AicardiGoutires syndrome, overlap with chilblain lupus

(2008) Athanassios Kolivras et al.   JOURNAL OF CUTANEOUS PATHOLOGY